Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 02, 2026
Why Is Leslie's (LESL) Stock Down -13.99% Today?

Why Is Leslie's (LESL) Stock Down -13.99% Today?

Key Takeaways

  • Move: Leslie's shares were down roughly 14%, trading near $0.1445 in early trading versus a prior-session close of $0.168.
  • Primary catalyst: The decline extends the selloff that followed the company's September 30 filing for prearranged Chapter 11 bankruptcy protection.
  • Secondary driver: Existing common shareholders face the prospect of heavy dilution or near-total loss of value as lenders are expected to take majority ownership on emergence.
  • Broader context: The stock has collapsed more than 97% over the past year, and the company now faces potential delisting from Nasdaq.
  • What to watch: Court approval of debtor-in-possession (DIP) financing, further store-closure announcements, and any details on the treatment of existing equity.

Opening Summary

Leslie's, Inc. (LESL), the largest direct-to-customer brand in the U.S. pool and spa care industry, extended its steep decline on Thursday, with shares trading down about 14% to near $0.1445 in early trading after closing the prior session at $0.168. The drop is the latest leg of a broader collapse triggered by the company's decision to file for prearranged Chapter 11 bankruptcy protection, a move that markets are interpreting as likely to leave existing equity holders with little or no recovery.

Chapter 11 Filing Drives Continued Selloff

The dominant force behind the move is Leslie's voluntary Chapter 11 filing in the U.S. Bankruptcy Court for the Southern District of Texas. Under a Restructuring Support Agreement backed by more than 80% of its existing lenders, the company plans to eliminate approximately $685 million—roughly 90%—of its funded debt, secure $90 million in new-money debtor-in-possession financing, and obtain $60 million in fully backstopped equity financing. The company also seeks approval for a $225 million DIP asset-based financing facility from its existing ABL lenders.

While the restructuring is designed to strengthen the balance sheet and keep the business operating, it carries severe implications for common shareholders. Upon emergence, which the company targets for early 2027, a group of existing lenders is expected to hold majority ownership. That ownership shift is widely seen as substantially diluting, or effectively wiping out, the value of existing shares—an outcome that has kept intense selling pressure on the stock in the days since the filing.

Store Closures and Equity Dilution Weigh on Sentiment

As part of the restructuring, Leslie's also announced the closure of 76 stores, adding an operational component to the financial reorganization. The company said it will continue to evaluate its real estate portfolio to align its footprint with long-term demand, signaling that additional closures remain possible. Although management stressed that the chain is "here to stay" and that remaining locations and digital platforms will continue operating without interruption, the combination of a shrinking store network and the pending transfer of ownership has deepened investor concerns about the path forward for equity holders.

Delisting and Financial Distress in Focus

Compounding the pressure, the company's securities filings reference a notice of delisting or failure to satisfy continued listing standards, a reminder that the stock's prolonged slide has put its Nasdaq listing at risk. The shares, which traded as high as $12.53 over the past year, have fallen to around $0.14, and the company had previously warned of substantial doubt about its ability to continue as a going concern. Weak peak-season results—third-quarter revenue declined 8.4% to $458.5 million—and the withdrawal of full-year guidance earlier this year underscored the operational challenges that preceded the filing.

Market Context and Trading Activity

Trading activity has been extraordinarily heavy relative to the stock's recent norm. Sessions immediately following the bankruptcy announcement saw volumes in the millions of shares, far above the several-hundred-thousand-share levels typical in prior weeks, reflecting active liquidation by investors exiting positions. The move is idiosyncratic rather than a reflection of broader market weakness: the collapse is tied directly to company-specific restructuring news rather than a sector or macroeconomic catalyst. Technically, the stock is trading near its 52-week low, well below prior support levels, with no meaningful recovery in sight as bankruptcy proceedings get underway.

What Comes Next for LESL

Looking ahead, investors will focus on the bankruptcy court's handling of the company's first-day motions, including approval of the DIP financing facilities intended to fund operations through the process. Additional store-closure announcements and further details on the treatment of existing common stock will be critical, since the restructuring agreement does not specify the ultimate recovery available to current shareholders. Risks remain elevated: the proceedings could result in full or near-full impairment of equity value, and the company must still demonstrate it can stabilize operations and cash flow while navigating delisting pressures. The path to emergence in early 2027 remains subject to court approval and execution risk.

Trending AI Robots

For traders seeking data-driven signals across thousands of stocks, Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots. Tickeron offers hundreds of bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, helping users explore automated approaches tailored to different market environments. Explore the Trending AI Robots page to see which strategies are currently leading.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LESL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


LESL sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for LESL moved below the 200-day moving average on September 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LESL as a result. In 86 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LESL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for LESL entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where LESL advanced for three days, in 177 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

LESL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LESL's P/B Ratio (-17.823) is slightly lower than the industry average of (1.755). P/E Ratio (175.500) is within average values for comparable stocks, (241.673). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (1.113). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (0.004) is also within normal values, averaging (1.033).

The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. LESL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LESL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ulta Beauty (NASDAQ:ULTA), Best Buy Company (NYSE:BBY), Tractor Supply Co (NASDAQ:TSCO), Five Below (NASDAQ:FIVE), GameStop Corp (NYSE:GME), Bath & Body Works (NYSE:BBWI), RH (NYSE:RH), 1-800-FLOWERS.COM (NASDAQ:FLWS).

Industry description

The specialty stores sector includes companies dedicated to the sale of retail products focused on a single product category, such as clothing, carpet, books, or office supplies. A specialty store could face intense competition from big-box departmental chains, and therefore offering an adequate collection of the product type it specializes in is key in maintaining/growing its market.

Market Cap

The average market capitalization across the Specialty Stores Industry is 4.13B. The market cap for tickers in the group ranges from 3.1K to 50.98B. ANCTF holds the highest valuation in this group at 50.98B. The lowest valued company is SIMPQ at 3.1K.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Stores Industry was -1%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 4%. ABLV experienced the highest price growth at 85%, while LESL experienced the biggest fall at -50%.

Volume

The average weekly volume growth across all stocks in the Specialty Stores Industry was 24%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was 28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 61
Price Growth Rating: 61
SMR Rating: 63
Profit Risk Rating: 90
Seasonality Score: 33 (-100 ... +100)
View a ticker or compare two or three
LESL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry SpecialtyStores

Industry
N/A
Address
2005 East Indian School Road
Phone
+1 602 366-3999
Employees
3790
Web
https://www.lesliespool.com
Interact to see
Advertisement
AMZN stock declined approximately -4% over the past 30 days amid concerns over elevated AI-driven capital expenditures pressuring margins. Over the past quarter, the stock fell around -13%, reflecting post-earnings selloff and broader tech sector volatility. Major drivers include surging AWS demand offset by high capex forecasts of up to $200 billion for 2026, macroeconomic pressures like trade policy risks, and geopolitical tensions impacting sentiment.
Taiwan Semiconductor Manufacturing Company (TSM), the world's largest dedicated semiconductor foundry, produces advanced integrated circuits for fabless firms such as Nvidia (NVDA), Apple (AAPL), and AMD (AMD). Operating a pure-play foundry model, TSMC avoids chip design, focusing instead on manufacturing. It holds over 50% market share in critical advanced nodes like 3nm and 5nm, which power AI applications, smartphones, and high-performance computing.
Taiwan Semiconductor Manufacturing Company Limited (TSM) ADRs rose 4.68% in the most recent completed session, climbing from a prior close of $316.50 to $331.32. The move comes after a brief two‑day pullback and reflects renewed buying interest as investors refocus on TSMC’s role at the center of the AI chip supply chain.
APA Corporation delivered strong Q4 2025 results, beating EPS estimates with $0.91 adjusted earnings per share and $1.0 billion full-year free cash flow. Stock surged over 45% in recent weeks amid rising oil prices and geopolitical tensions, hitting 52-week highs near $45.66. 2026 capital plan set at $2.1 billion, targeting cost savings run-rate of $450 million and flat U.S. oil production.
I've been watching DVN closely in recent sessions, and it's held up well amid a broader energy sector rally driven by elevated oil prices. The stock has outperformed broader indices, which speaks to investor confidence in its strong positioning in U.S. shale plays, especially the Permian Basin. Volatility remains a factor with macroeconomic pressures and commodity swings, but the company's emphasis on capital discipline and returns to shareholders has encouraged steady buying. Trading volumes have increased, indicating growing interest as DVN manages merger developments and production shifts in this market cycle.
LLY stock declined -13% over the past 30 days amid concerns over obesity drug pricing pressures and competition from NVO. Over the past quarter, the stock fell around -17%, despite strong Q4 2025 earnings driven by Mounjaro and Zepbound volume growth. Bearish analyst notes on market saturation and potential price wars outweighed positive trial data for next-gen drugs like retatrutide.
I've been keeping a close eye on EOG Resources (EOG), and it's clear the stock has held up well through recent volatility. Year-to-date gains are approaching 38%, which stands out against the broader energy sector. The shares are trading above key moving averages, supported by investor confidence in the company's low-cost production and diversified multi-basin portfolio. Elevated crude oil prices have provided a tailwind, even as macroeconomic pressures have led to occasional dips. With a solid balance sheet and reliable free cash flow, EOG looks well-positioned in this market cycle.
Diamondback Energy (FANG), a leading independent oil and natural gas producer focused on the Permian Basin, has shown impressive resilience lately. In my view, the stock's climb of around 16% over recent weeks stands out, especially as it has traded near its 52-week high while outperforming key energy indices and the broader market. This momentum seems driven by favorable oil price dynamics, positive analyst revisions, and the company's operational efficiency paired with its exposure to rising crude benchmarks. Even with broader market fluctuations, FANG's robust cash flows and recent dividend enhancements continue to draw interest from both momentum traders and long-term investors.
MTDR stock surged +20% over the past 30 days, driven by escalating oil prices amid Iran conflict disruptions and strong Q4 2025 earnings beat. Over the past quarter, shares climbed +53%, fueled by record production, positive 2026 guidance, and analyst price target upgrades.
I've been watching OXY closely, and it's clear the stock has shown robust strength in recent trading sessions. It's advanced amid heightened oil prices driven by global supply concerns, outperforming broader indices. This reflects investor confidence in its Permian Basin dominance and operational resilience. Trading near the upper end of its 52-week range, OXY benefits from elevated crude realizations that enhance margins in its core upstream business. While sector peers have also gained, the company's focus on cost efficiencies and debt reduction positions it favorably in the latest market cycle. Heightened volume underscores sustained interest as macroeconomic pressures test energy equities.
I've been watching Antero Resources (AR) closely through recent trading sessions, where the stock has handled volatility well amid natural gas price swings and broader energy sector shifts. It's trading near the upper end of its 52-week range, with year-to-date gains exceeding +25%. From what I see, this reflects investor confidence in the company's growing Marcellus footprint and its disciplined approach to capital allocation. The upward momentum ties directly to positive analyst revisions and a solid production outlook. Macro factors like LNG export demand and data center growth continue to support sentiment in the natural gas space.
I've been tracking Magnolia Oil & Gas (MGY) closely, and it's clear the stock has put in a strong showing lately. It's trading near the top of its 52-week range, buoyed by positive dynamics in the energy sector. From what I see, investor interest in oil and gas producers like MGY is picking up, thanks to improved production efficiency and a focus on capital discipline. The shares have held up well, with a PE ratio around 18 and a dividend yield close to 2%. Sector-wide support from stronger commodity prices has helped drive this momentum, placing MGY in a solid spot among exploration and production peers. Trading volume reflects this engagement, aligning with the broader uptick in activity.
PR stock surged +18% over the past 30 days, driven by investment-grade credit rating upgrades from S&P and Fitch, analyst price target increases, and rising oil prices. Over the past quarter, shares climbed +55%, fueled by record Q4 2025 production, strong earnings beat, dividend hike, and robust operational efficiencies. Key factors include credit upgrades enhancing financial flexibility, positive analyst sentiment with multiple buy ratings, and favorable sector trends from higher crude oil realizations.
RRC stock rose +11% over the past 30 days, driven by strong Q4 2025 earnings beat, dividend hike, and positive 2026 guidance. Over the past quarter, shares gained +31%, reflecting robust free cash flow generation and operational efficiency in the Appalachian Basin.
From what I see, Exxon Mobil Corporation (XOM) stands out as one of the world's largest integrated energy companies, involved in the exploration, production, refining, and marketing of oil, natural gas, and petrochemicals. Its business model covers the full hydrocarbon value chain, from upstream production to downstream refining and chemicals, which offers diversification against commodity price swings. In the oil and gas industry, Exxon Mobil maintains a leading position thanks to its vast reserves, especially in high-return areas like the Permian Basin in the U.S. and offshore Guyana. The company's strong fundamentals—record production volumes and ongoing cost savings—have supported recent stock strength, as higher oil prices boost upstream earnings and refining profits from wider margins.
I've been watching TMV closely through recent trading sessions, where it's handled heightened volatility linked to swings in long-term Treasury yields. This ETF delivers -3x the inverse daily performance of 20+ year U.S. Treasuries, and it's held up well amid pressures in the broader fixed income space. From what I see, rising energy costs and macroeconomic uncertainties have driven yields higher, which plays right into TMV's strengths. The fund is trading within its 52-week range, backed by strong liquidity and substantial daily volume—making it suitable for active traders looking to position around rate-sensitive moves. Recent market cycles really underscore TMV's value in tactical strategies tied to bond market shifts.
From what I see, Constellation Energy stands out as the largest producer of carbon-free energy in the U.S., with the nation's biggest nuclear fleet boasting over 21 GW of capacity—that's roughly 10% of U.S. clean energy output. This scale delivers unmatched reliability for baseload power, which is exactly what hyperscalers like Microsoft and Meta need for their 24/7 carbon-free electricity demands to power AI data centers. Post-Calpine acquisition, the company's ~55 GW fleet now spans nuclear, natural gas, and renewables, providing geographic diversity across key markets like PJM and ERCOT.
In my view, Karman Holdings Inc. (KRMN) really stands out in the aerospace and defense sector with its focus on mission-critical subsystems, including payload protection and deployment systems, aerodynamic interstage systems, and propulsion systems. The company serves high-growth markets like hypersonics, strategic missile defense, tactical missiles, and space launch, benefiting from proprietary engineering and manufacturing capabilities that enable rapid development for prime contractors.
As one of the top three global players in the semiconductor memory market, Micron Technology holds about 22% share in DRAM and is building a stronger foothold in NAND flash storage. What stands out to me is the company's leadership in high-bandwidth memory (HBM), which is essential for AI accelerators. By early 2026, Micron has secured around 21% market share here, thanks to its efficient 12-high and 36GB HBM4 stacks that use 30% less power than competitors.
I've been following Viridian Therapeutics ($VRDN) closely as it carves out a strong position in the thyroid eye disease (TED) market—a rare autoimmune disorder that causes orbital inflammation, proptosis, diplopia, and even vision loss in severe cases. The company draws on its antibody discovery and protein engineering expertise to create differentiated IGF-1R inhibitors, building on the validated pathway pioneered by Tepezza (teprotumumab). What stands out to me is how veligrotug diverges from Tepezza's frequent IV infusions: it offers a more convenient 12-week course with robust efficacy demonstrated in Phase 3 trials for both active and chronic TED, which could help it gain market share through better patient tolerability.